Preparation and characterization of coenzyme Q10-loaded PMMA nanoparticles by a new emulsification process based on microfluidization

被引：53

作者：

Kwon, SS ^{[1
]}

Nam, YS ^{[1
]}

Lee, JS ^{[1
]}

Ku, BS ^{[1
]}

Han, SH ^{[1
]}

Lee, JY ^{[1
]}

Chang, IS ^{[1
]}

机构：

[1] Amore Pacific R&D Ctr, Nanotechnol Res Team, Yongin Si 449729, Gyounggi Do, South Korea

来源：

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS | 2002年 / 210卷 / 01期

关键词：

coenzyme Q(10); nanoparticles; microfluidization; poly(methyl methacrylate); drug stability;

D O I：

10.1016/S0927-7757(02)00212-1

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

A microfluidization and solvent evaporation method was employed to prepare poly(methyl methacrylate) (PMMA) nanoparticles containing coenzyme Q(10). Dynamic light scattering and transmission electron microscopy showed that the mean diameter of the nanoparticles was highly influenced by the kind of surfactants used and the recycling number of the microfluidization process. Particles with sizes from 40 to 260 nm and low polydispersities were produced with good reproducibility. Despite a very high target drug loading yield, 38.7% (w/w), the actual loading efficiency reached above 95%, as demonstrated by H-1 NMR analysis. Coenzyme Q(10) formed a crystal structure within the polymer matrix with a melting temperature of 48 degreesC, as demonstrated by differential scanning calorimetry. No free drug crystals were found in the aqueous suspension of nanoparticles. A comparative study on structural stability of coenzyme Q(10) showed that both UV and high temperature-induced drug inactivation were effectively hindered when the drug was encapsulated within the polymer nanoparticles. (C) 2002 Elsevier Science B.V. All rights reserved.

引用

页码：95 / 104

页数：10

共 18 条

[11] Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:: formulation development and bioavailability assessment [J].

Kommuru, TR ;

Gurley, B ;

Khan, MA ;

Reddy, IK .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :233-246

[12] Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method [J].

Kwon, HY ;

Lee, JY ;

Choi, SW ;

Jang, YS ;

Kim, JH .

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2001, 182 (1-3) :123-130

[13]

NAZZAL S, 2001, P 28 INT S CONTR REL

[14] Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury [J].

Niibori, K ;

Yokoyama, H ;

Crestanello, JA ;

Whitman, GJR .

JOURNAL OF SURGICAL RESEARCH, 1998, 79 (02) :141-145

[15] Biodegradable polymeric nanoparticles as drug delivery devices [J].

Soppimath, KS ;

Aminabhavi, TM ;

Kulkarni, AR ;

Rudzinski, WE .

JOURNAL OF CONTROLLED RELEASE, 2001, 70 (1-2) :1-20

[16]

*US FDA, 1996, IN INGR GUID RED, P133

[17] Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release [J].

Yoo, HS ;

Oh, JE ;

Lee, KH ;

Park, TG .

PHARMACEUTICAL RESEARCH, 1999, 16 (07) :1114-1118

[18] Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method [J].

Zambaux, MF ;

Bonneaux, F ;

Gref, R ;

Maincent, P ;

Dellacherie, E ;

Alonso, MJ ;

Labrude, P ;

Vigneron, C .

JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :31-40

← 1 2 →